LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global cardiovascular catheters market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

The global cardiovascular catheters market is growing moderately during the forecast period. Globally, the sales of cardiovascular catheters will increase due to the rise in the incidence of structural heart and CHD. Treatment and diagnosis by using cardiovascular catheters can decrease the number of heart failures, heart attacks, and stroke cases.

Srinivas Sashidhar, a lead analyst from Technavio, specializing in research on cardiovascular devices sector, says, “Technological advances led to the adoption of MI procedures for angioplasty, which increases the demand for next-generation balloon catheters. To treat the increasing number of people with arrhythmias and provide improved medical outcomes, vendors are extensively investing in the R&D of advanced ablation devices and catheters. They are using advanced endoscopy technologies to develop innovative products.”

The top three emerging trends driving the global cardiovascular catheters market according to Technavio research analysts are:

Business strategies to emerge in the market
Increase in M&A
Integration of robotic cardiac catheter system and hybrid operating room equipment
Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Business strategies to emerge in the market

Stryker reprocesses single-use medical devices such as cardiovascular therapeutic and diagnostic catheters through its department named Stryker Sustainability Solutions. Though reprocessed single-use cardiovascular catheters can arise questions on their medical safety, the products are processed and sterilized in such a way, which decreases the chances of infection.

“A medical device in combination with the pharmacological product can be more helpful in the treatment of cardiovascular diseases, especially DEBs. Companies should focus on partnership with pharma companies, which can lead to the development of novel products,” according to Srinivas.

Increase in M&A

Vendors undergo M&A to extend their product offerings, increase their market shares, and expand their operations. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. The acquisition allows vendors to access the product portfolio of the acquired company.

M&A helps large companies to increase their product portfolio, and for small companies, it increases the chance to penetrate the market. It increases market competitiveness, which thrives companies to focus on the development of innovative products in the market.

Integration of robotic cardiac catheter system and hybrid operating room equipment

Hybrid ablation is a growing market trend, which is at the clinical research stage. It combines surgery and catheter ablation to treat AF. To increase the precision of the surgery and improve efficacy, the adoption of robotic-assisted surgery is increasing in the market. Robotic cardiac ablation systems such as Stereotaxis Niobe magnetic navigation system are used for interventional imaging during surgery.

Hybrid operating rooms have become a standard in hospitals in the US, as devices such as hybrid operating suites and operating room-integration systems allow the surgical team to perform error-free surgical procedures, control the devices, and receive patient information.

The key vendors are as follows:

Boston Scientific
St. Jude Medical
C. R. Bard
Medtronic